Strategic Advisory Group of Experts on Immunization and WHO makes new recommendations for vaccines to battle typhoid fever and rabies: October 2017
Polio eradication initiative:
To date, 4 countries have decided to move to a fractional inactivated poliovirus
The US Food and Drug Administration (FDA) has approved golimumab (Simponi Aria, Janssen Biotech) for adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS).
Golimumab, an inhibitor of tumor necrosis factor (TNF)-α, is already approved for treatment
US Food and Drug Administration (FDA) advisory panel voted nearly unanimously in favor of approval for Novo Nordisk's once-weekly injectable semaglutide, despite a signal for increased retinopathy. If approved, it would be the seventh GLP-1 receptor agonist on the US market and
The US Food and Drug Administration (FDA) has approved ustekinumab (Stelara) for the treatment of adolescents with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, announced Janssen.
This marks a significant milestone for adolescents a
Patients who discontinue long-term, low-dose aspirin therapy for reasons other than surgery or bleeding face an increased risk of cardiovascular events, a large population-based study suggests.
After a median 3 years of follow-up, patients who stopped taking aspirin had a 37%
It is celebrated annually to raise awareness about rabies prevention and to highlight progress in defeating this horrifying disease.
28 September also marks the anniversary of Louis Pasteur's death, the French chemist and microbiologist, who developed the first rabies vaccine.
The lack of trust shown towards doctors by the people in Nepal is a problem that has been around for quite some time now.
The issue has multiple reasons- the biggest of which is probably the mainstream media which carries and amplifies news with negative connotations for docto
The US Food and Drug Administration (FDA) last week approved an antibiotic called secnidazole (Solosec, SECZYLDJPL(division2)Therapeutics) for women with bacterial vaginosis.
Secnidazole is the first single-dose oral treatment